$PHG

Global healthcare computer vision market projected to surge from $4.37B in 2026 to $33.4B by 2036, driven by AI diagnostics and radiologist shortages.

Healthcare analytics market projected to grow 24% annually from $56B (2025) to $390B (2034), driven by EHR adoption, AI integration, and value-based care models.

Philips beat Q1 earnings expectations with 27-cent EPS versus 23-cent consensus, driven by 6% order growth and strong operational leverage, though revenue missed guidance slightly.

Global sleep apnea devices market expected to grow 7.05% annually through 2034, driven by rising prevalence and technological advances in CPAP and BiPAP devices.

Philips launches Bridge Plus Occlusion Balloon for cardiac emergency management, improving SVC tear survival rates from 56.9% to 88.2%, now available in U.S. markets.

Global respiratory care devices market projected to grow 8% annually to $47.5B by 2034, driven by chronic disease prevalence and home healthcare demand.

Royal Philips secured FDA 510(k) clearance for its Rembra platform, enabling faster CT imaging and radiation therapy planning with capacity for 270 daily exams.

Global ambulatory surgical equipment market projected to double from $7.39B in 2026 to $14.58B by 2035, driven by demand for minimally invasive procedures.

Philips gains FDA clearance for Verida, an AI-powered spectral CT system enabling 270 daily exams and sub-30-second scan times.

IoT healthcare market projected to reach $483.72 billion by 2031, growing at 18.46% CAGR from $207.4 billion in 2026, driven by remote monitoring and connected devices.

Philips appoints Chief Medical Officer Dr. Carla Goulart Peron to MDIC board, strengthening industry influence over FDA medical device regulatory standards.

Philips launches FDA-cleared IntraSight Plus interventional platform, offering up to 47% cathlab operation time savings with integrated diagnostic and treatment planning capabilities.

Philips launches cloud-based digital pathology platform powered by AWS, enabling healthcare organizations to scale diagnostic workflows without on-premise infrastructure.

Global respiratory testing market projected to reach $9.32B by 2032, growing 6.50% annually from $5.99B in 2025, driven by molecular diagnostics and telemedicine innovations.

Royal Philips coordinates seven clinical trials across Europe to validate AI-assisted robotics for brain and liver tumor treatments, addressing physician shortages.

Global anti-snoring devices market projected to nearly double to $3.36 billion by 2033, driven by obesity, health awareness, and technological advances.

Healthcare digital twins market expected to surge from $2.22B in 2025 to $69.67B by 2035, driven by AI integration and precision medicine adoption.

TSMC is critical to global AI infrastructure, manufacturing cutting-edge processors for major tech firms. Its foundry model and advanced capabilities position it to benefit from sustained AI demand.

Remote patient monitoring market projected to grow from $36.6B (2026) to $164.5B (2035) at 18.18% annual growth, driven by chronic disease prevalence and aging populations.